Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...

A single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...

A gene therapy treatment has enabled sight improvements for blind infants, through pioneering work by University College ...

Gene therapy involves the introduction of new genes ... In a recently reported study, a novel engineered oncolytic Newcastle disease virus encoding porcine α1,3-galactosyltransferase was ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...

Four children born with a rare genetic form of severe blindness have all experienced significant improvements in their ...

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...